S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q3 2024

Deep Track Capital

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$3.15B
Total portfolio value
Positions
71
Reported securities
Top Holding
ARGX
6.3% $197.9M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ARGXARGENX SE$197.9M6.28%$542.08$939.68+73.3%
6.3%
DVAXDYNAVAX TECHNOLOGIES CORP$139.6M4.43%β€”β€”
4.4%
GHGUARDANT HEALTH INC$137.7M4.37%$22.94$167.98+632.3%
4.4%
APLSAPELLIS PHARMACEUTICALS INC$126.9M4.03%$28.84β€”
4.0%
IMVTIMMUNOVANT INC$124.0M3.93%$28.51$38.79+36.1%
3.9%
SWTXSPRINGWORKS THERAPEUTICS INC$123.2M3.91%β€”β€”
3.9%
DYNDYNE THERAPEUTICS INC$117.9M3.74%$35.92$23.07-35.8%
3.7%
ITCIINTRA-CELLULAR THERAPIES INC$117.1M3.72%β€”β€”
3.7%
OCULOCULAR THERAPEUTIX INC$110.7M3.51%$8.70$9.64+10.8%
3.5%
NTLAINTELLIA THERAPEUTICS INC$101.7M3.23%$20.55$17.56-14.6%
3.2%
ALKSALKERMES PLC$98.0M3.11%$27.99$54.58+95.0%
3.1%
VRNAVERONA PHARMA PLC$91.5M2.90%β€”β€”
2.9%
IONSIONIS PHARMACEUTICALS INC$88.1M2.80%$40.06$81.80+104.2%
2.8%
NRIXNURIX THERAPEUTICS INC$86.9M2.76%$22.47$23.97+6.7%
2.8%
VRDNVIRIDIAN THERAPEUTICS INC$85.3M2.71%$22.75$19.40-14.7%
2.7%
BCYCBICYCLE THERAPEUTICS PLC$80.3M2.55%$22.63$4.35-80.8%
2.5%
MBXMBX BIOSCIENCES INC$78.4M2.49%$25.98$57.80+122.5%
2.5%
AXSMAXSOME THERAPEUTICS INC$77.0M2.44%$89.87$244.31+171.8%
2.4%
PLRXPLIANT THERAPEUTICS INC$67.0M2.12%$11.21$1.17-89.6%
2.1%
APGEAPOGEE THERAPEUTICS INC$58.7M1.86%$58.74$132.91+126.3%
1.9%
AUTLAUTOLUS THERAPEUTICS PLC$55.4M1.76%$3.63$1.58-56.5%
1.8%
GPCRSTRUCTURE THERAPEUTICS INC$53.6M1.70%$43.89$53.45+21.8%
1.7%
OLMAOLEMA PHARMACEUTICALS INC$47.8M1.51%$11.94$12.64+5.9%
1.5%
TERNTERNS PHARMACEUTICALS INC$46.5M1.48%$8.34β€”
1.5%
FDMT4D MOLECULAR THERAPEUTICS IN$44.3M1.40%$10.81$13.00+20.3%
1.4%
ABVXABIVAX SA$41.2M1.31%$11.52$144.65+1155.6%
1.3%
TGTXTG THERAPEUTICS INC$40.4M1.28%$23.39$53.31+127.9%
1.3%
MNMDMIND MEDICINE MINDMED INC$40.2M1.28%β€”β€”
1.3%
KURAKURA ONCOLOGY INC$38.4M1.22%$19.54$11.10-43.2%
1.2%
GERNGERON CORP$34.4M1.09%$4.54$1.36-70.0%
1.1%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (8)

TickerIssuerNotionalSince Filing
MBXMBX BIOSCIENCES INC$78.4M+122.5%
ORKAORUKA THERAPEUTICS INC$30.3M
RNAMAVIDITY BIOSCIENCES INC$21.8M
CNTACENTESSA PHARMACEUTICALS PLC$21.6M
BCAXBICARA THERAPEUTICS INC$20.3M
AKROAKERO THERAPEUTICS INC$19.8M
XNCRXENCOR INC$16.1M
HELPCYBIN INC$13.6M

Exited Positions (8)

TickerIssuerNotional
AMGNAMGEN INC$179.7M
INSMINSMED INC$134.0M
ALNYALNYLAM PHARMACEUTICALS INC$121.5M
HLVXHILLEVAX INC$26.5M
PRAXPRAXIS PRECISION MEDICINES I$16.1M
CYBNXXXXCYBIN INC$15.8M
AGENAGENUS INC$5.3M
RPTXREPARE THERAPEUTICS INC$3.0M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
EWTXEDGEWISE THERAPEUTICS INC$26.0M+490.5%
KURAKURA ONCOLOGY INC$30.4M+410.3%-43.2%
CYTKCYTOKINETICS INC$26.1M+375.4%
NMRACALLNEUMORA THERAPEUTICS INC.$5.7M+214.4%
VIGLVIGIL NEUROSCIENCE INC$2.9M+160.2%
APLSAPELLIS PHARMACEUTICALS INC$31.0M+76.0%
IMVTIMMUNOVANT INC$47.8M+50.8%+36.1%
GHGUARDANT HEALTH INC$7.7M+33.3%+632.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
TVTXTRAVERE THERAPEUTICS INC$-53.1M-92.8%
AXSMCALLAXSOME THERAPEUTICS INC$-131.2M-89.2%+171.8%
SRRKSCHOLAR ROCK HLDG CORP$-2.7M-87.1%
KYMRKYMERA THERAPEUTICS INC$-16.4M-60.0%
ANROALTO NEUROSCIENCE INC$-3.0M-57.1%
AXSMCALLAXSOME THERAPEUTICS INC$-72.1M-53.7%+171.8%
RLMDRELMADA THERAPEUTICS INC$-1.5M-45.3%
CLYMELIEM THERAPEUTICS INC$-16.7M-44.4%
← Back to Hedge Funds